CRUK suggests the molecule could offer improved anti-tumor activity with fewer side effects compared to antibody-based approaches.
The Cambridge Science Park company and its sister firm will receive an upfront payment of $20million.
‘I wasn’t particularly good at school,’ he admits.
Several enzymes have been identified under the collaboration.
Chinese Medical Systems will offer seed investment capital in five-year programme.
He has led the robotics company from start-up to billion-dollar status and it is set to transform minimal access surgery.
The Cambridge company will use its Healnet AI platform to help identify new indications.
Coaching cells to revert to healthy activity is core of simplified process
Zydis technology will be applied to four of the Cambridge company’s products.
The St John’s Innovation Park company will integrate its platform into Veeva CRM Suggestions
PRECIOUS study follows successful launch of IBD prognostic test in UK and Ireland.
Staff and assets at its US-based research models business will transfer over.
Chris Russo's group has shown how the prohibitive costs of cryo-electron microscopy could be slashed.